Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$10.46 USD
-0.03 (-0.29%)
Updated Oct 28, 2025 04:00 PM ET
After-Market: $10.46 0.00 (0.00%) 5:20 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Dynavax Technologies Corporation has a market cap of $1.23B, which represents its share price of $10.49 multiplied by its outstanding shares number of 117.27M. As a small-cap company, DVAX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
DVAX 10.46 -0.03(-0.29%)
Will DVAX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for DVAX based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for DVAX
Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?
Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates
DVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates
Exelixis (EXEL) Beats Q2 Earnings Estimates
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
Other News for DVAX
Is DVAX set to rally? Stochastic Reached Overbought shows up after rising 1.06%
Dynavax Technologies Advances in Pneumonic Plague Vaccine Study
DVAX forms Bollinger Band Squeeze on October 24
DVAX forms 50 Day Moving Average Support on October 23
50 Day Moving Average Support appears for DVAX after 0.3% move